MBX Biosciences Inc. Comm...

NASDAQ: MBX · Real-Time Price · USD
14.74
1.53 (11.58%)
At close: Aug 15, 2025, 3:59 PM
14.92
1.22%
After-hours: Aug 15, 2025, 07:58 PM EDT

MBX Biosciences Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-61.92M -32.56M -26.14M
Depreciation & Amortization
244K 157K 56K
Stock-Based Compensation
5.22M 2.04M 306K
Other Working Capital
670K -1.15M 619K
Other Non-Cash Items
-2.82M -880K 1.36M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
4.6M -735K 1.29M
Operating Cash Flow
-54.68M -31.98M -23.12M
Capital Expenditures
-874K -129K -441K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-239.47M -63.8M -20.22M
Sales Maturities Of Investments
79.75M 33M 9.25M
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-160.59M -30.93M -11.41M
Debt Repayment
n/a n/a 10M
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
-3.94M 709K -428K
Financial Cash Flow
234.1M 69.22M 46.06M
Net Cash Flow
18.83M 6.31M 11.53M
Free Cash Flow
-55.55M -32.11M -23.56M